Cell-free supernatant of Levilactobacillus brevis (RAMULAB51) from coconut inflorescence sap (Neera) enhances glucose uptake and PPAR-γ in 3T3-L1 adipocytes and inhibits α-glucosidase and α-amylase
2024

Coconut Sap Probiotic Enhances Glucose Uptake and Reduces Blood Sugar

publication 10 minutes Evidence: moderate

Author Information

Author(s): Kumari V B Chandana, Ramu Ramith, Shirahatti Prithvi S., Alam Perwez, Wong Ling Shing

Primary Institution: JSS Academy of Higher Education and Research, Mysore, Karnataka, India

Hypothesis

Can the cell-free supernatant of Levilactobacillus brevis from coconut sap improve glucose metabolism and inhibit digestive enzymes?

Conclusion

The study shows that RAMULAB51 can significantly enhance glucose uptake and inhibit enzymes related to carbohydrate digestion, suggesting its potential for diabetes management.

Supporting Evidence

  • RAMULAB51 showed the highest enzyme inhibition rates for α-glucosidase and α-amylase.
  • Enhanced glucose uptake was observed in 3T3-L1 adipocytes treated with RAMULAB51.
  • Activation of PPAR-γ was noted alongside increased glucose uptake.
  • RAMULAB51 demonstrated significant antimicrobial activity against various pathogens.

Takeaway

This study found that a probiotic from coconut sap can help your body use sugar better and stop some sugars from turning into glucose, which is good for managing diabetes.

Methodology

The study involved isolating lactic acid bacteria from coconut sap, characterizing them, and testing their effects on glucose uptake and enzyme inhibition in 3T3-L1 adipocytes.

Limitations

Further in vivo research is needed to confirm the therapeutic benefits of RAMULAB51.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fmicb.2024.1497023

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication